| Literature DB >> 30893318 |
A Thi Win Shwe1,2, Arthorn Riewpaiboon1, Usa Chaikledkaew1, Sitaporn Youngkong1.
Abstract
Maternal health still remains a major challenge in almost all developing countries. In Myanmar, the country met only 62% of its target for the maternal mortality rate (130 per 100,000 live birth) even though proportion of skilled birth attendant (SBA) and antenatal care (ANC) coverage was 80% in 2015. Despite the estimated large maternal complications, most maternal healthcare program ignored the burden of those morbidity because of limited understanding of the incidence and prevalence of morbidity conditions and cost of those morbidity burdens on society. The present study provides a general idea of the scope of obstetric complication, incidence of obstetric complication, and cost of those morbidity burdens on society. We conducted a retrospective incidence-based cost of illness study related to obstetric complication from the healthcare system perspective at 25 bedded township hospital in Yedashae during the fiscal year of 2015-2016. For the cost of obstetric complication, average treatment cost was 26.83 USD (±8.59). When looking by disease category, average treatment cost for incomplete abortion was 35.45 USD (±1.75); pelvic inflammatory disease (PID) was 16.01 USD; pregnancy-induced hypertension (PIH) was 21.02 USD (±4.68); ante-partum hemorrhage (APH) was 14.24(± 0.25); post-partum hemorrhage (PPH) was 27.04 USD (±1.56); prolonged labor was 37.55 USD (±0.42); and septicemia was 16.51 USD (±2.15). Significant predicting variables in obstetric complication cost model were incomplete abortion, prolonged labor, post-partum hemorrhage (PPH), pregnancy induced hypertension (PIH), patient age and septicemia. From this study, we can summarize the most frequently occurred obstetric complication in that township area, actual cost burden of those complications and obstetric complication cost model which can be useful for hospital financial management. This study can be considered as a starting point for cost of illness analysis in Myanmar to prioritize and target specific health problem at a country level for policy maker to set priorities for health care intervention.Entities:
Mesh:
Year: 2019 PMID: 30893318 PMCID: PMC6426195 DOI: 10.1371/journal.pone.0213141
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic data of hospitalized patients with obstetric complication in Yedashae township hospital (2015 fiscal year).
| Variables | Patients with obstetric complication (n = 91) |
|---|---|
| 26.75 (±5.09) | |
| 19–39 | |
| 64 (70.3%) | |
| 27 (29.7%) | |
| 60 (65.9%) | |
| 31 (34.1%) | |
| 3.12 | |
| 3 | |
| 2–5 | |
| 77 (84.6%) | |
| 14 (15.4%) | |
| 26 (28.5%) | |
| 1 (1.1%) | |
| 23 (25.3%) | |
| 11 (12.1%) | |
| 17(18.7%) | |
| 9 (9.9%) | |
| 4 (4.4%) |
Unit cost of medicals (USD in 2015 values).
| Name of basic medical service | Unit cost |
|---|---|
| Operation | 10.37 |
| Out Patient Department (OPD) visit | 1.60 |
| Inpatient Department (IPD); admission | 9.48 |
| Inpatient Department (IPD); patient day | 2.02 |
| Adult Chest X-ray | 6.97 |
| Arms, Legs and Knee X-ray | 6.74 |
| Child X-ray | 6.67 |
| Human Immunodeficiency Virus (HIV) test | 3.15 |
| Hepatitis B Surface Antigen (HBs-Ag) test | 0.56 |
| Hepatitis C Virus (HCV) test | 1.04 |
| Venereal Disease Research Laboratory (VDRL) test | 0.77 |
| Hemoglobin (Hb) test | 0.25 |
| Complete Picture (CP) test for blood | 1.67 |
| Randon Blood Sugar (RBS) test | 0.40 |
| Erythrocyte Sedimentation Rate (ESR) | 4.07 |
| Packed Cell Volume (PCV) test | 0.43 |
| Bleeding Time (BT), Clotting Time (CT) | 0.75 |
| Grouping and Matching (G & M) | 0.42 |
| Rh Blood Group Test | 0.40 |
| Malaria Parasite (MP) test (with Film) | 1.22 |
| Malaria Parasite (MP) (With Immunochromatographic Assay (ICT)) | 1.03 |
| Ziehl-neelsen stain (Z-N stain) test | 1.06 |
| Urine Re | 1.38 |
| Urine Re (test strip) | 0.44 |
| Urine Chorionic gonadotrophin (UCG) test | 0.11 |
| Stool Re | 0.66 |
1 USD = 1,199.07 MMK in 2015 average exchange rate, NA = Not Applicable
Fig 1Percentage of total treatment cost by disease category (2015 fiscal year).
Total and average direct medical cost by disease category (USD) (Mean ± SD, medium).
| Complication by | Average Treatment Cost/Case | Total treatment Cost (Total Direct Medical Cost) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug cost | Laboratory cost | Routine service cost | Operation theatre cost | Average Treatment Cost (Average Direct medical cost) | ||||||||||||
| Mean | SD | Median | Mean | SD | Median | Mean | SD | Median | Mean | SD | Median | Mean | SD | Median | ||
| 10.42 | 1.04 | 10.36 | 9.38 | 0 | 9.38 | 5.27 | 1.00 | 6.05 | 10.37 | 0 | 10.37 | 35.45 | 1.75 | 35.45 | 921.74 | |
| Age <30 (n = 21) | 10.24 | 0.99 | 10.30 | 9.38 | 0 | 9.38 | 5.09 | 1.03 | 6.05 | 10.37 | 0 | 10.37 | 35.08 | 1.70 | 34.87 | 736.76 |
| Age≥30 (n = 5) | 11.19 | 0.98 | 10.78 | 9.38 | 0 | 9.38 | 6.05 | 0 | 6.05 | 10.37 | 0 | 10.37 | 37 | 0.98 | 36.59 | 184.98 |
| 7.96 | 0 | 7.96 | 0.40 | 0 | 0.40 | 7.65 | 0 | 7.65 | 0 | 0 | 0 | 16.01 | 0 | 16.01 | 16.01 | |
| Age <30 (n = 1) | 7.96 | 0 | 7.96 | 0.40 | 0 | 0.40 | 7.65 | 0 | 7.65 | 0 | 0 | 0 | 16.01 | 0 | 16.01 | 16.01 |
| Age≥30 (n = 0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 8.99 | 2.14 | 9.30 | 3.50 | 0.81 | 3.86 | 8.53 | 2.18 | 9.67 | 0 | 0 | 0 | 21.02 | 4.68 | 22.82 | 483.46 | |
| Age <30 (n = 12) | 7.79 | 2.24 | 8.71 | 3.34 | 0.94 | 3.86 | 6.98 | 1.57 | 6.65 | 0 | 0 | 0 | 18.11 | 4.33 | 19.22 | 217.32 |
| Age≥30 (n = 11) | 10.30 | 0.96 | 10.07 | 3.67 | 0.63 | 3.86 | 10.22 | 1.30 | 9.67 | 0 | 0 | 0 | 24.19 | 2.50 | 23.61 | 266.14 |
| 2.85 | 0.25 | 2.87 | 9.78 | 0 | 9.78 | 1.60 | 0 | 1.60 | 0 | 0 | 0 | 14.24 | 0.25 | 14.26 | 156.59 | |
| Age <30 (n = 7) | 2.74 | 0.24 | 2.87 | 9.78 | 0 | 9.78 | 1.60 | 0 | 1.60 | 0 | 0 | 0 | 14.12 | 0.24 | 14.26 | 98.86 |
| Age≥30 (n = 4) | 3.05 | 0.12 | 3.10 | 9.78 | 0 | 9.78 | 1.60 | 0 | 1.60 | 0 | 0 | 0 | 14.43 | 0.12 | 14.49 | 57.73 |
| 5.28 | 1.56 | 4.45 | 9.78 | 0 | 9.78 | 1.60 | 0 | 1.60 | 10.37 | 0 | 10.37 | 27.04 | 1.56 | 26.21 | 459.73 | |
| Age <30 (n = 15) | 5.39 | 1.63 | 4.45 | 9.78 | 0 | 9.78 | 1.60 | 0 | 1.60 | 10.37 | 0 | 10.37 | 27.15 | 1.63 | 26.21 | 407.32 |
| Age≥30 (n = 2) | 4.45 | 0 | 4.45 | 9.78 | 0 | 9.78 | 1.60 | 0 | 1.60 | 10.37 | 0 | 10.37 | 26.21 | 0 | 26.21 | 52.41 |
| 11.35 | 0.42 | 11.67 | 9.78 | 0 | 9.78 | 6.05 | 0 | 6.05 | 10.37 | 0 | 10.37 | 37.55 | 0.42 | 37.87 | 337.99 | |
| Age <30 (n = 5) | 11.38 | 0.43 | 11.67 | 9.78 | 0 | 9.78 | 6.05 | 0 | 6.05 | 10.37 | 0 | 10.37 | 37.58 | 0.43 | 37.87 | 187.90 |
| Age≥30 (n = 4) | 11.32 | 0.47 | 11.33 | 9.78 | 0 | 9.78 | 6.05 | 0 | 6.05 | 10.37 | 0 | 10.37 | 37.52 | 0.47 | 37.54 | 150.09 |
| 6.34 | 0.24 | 6.34 | 0 | 0 | 0 | 10.17 | 1.93 | 10.68 | 0 | 0 | 0 | 16.51 | 2.15 | 17.01 | 66.04 | |
| Age <30 (n = 3) | 6.27 | 0.24 | 6.13 | 0 | 0 | 0 | 9.67 | 2.02 | 9.67 | 0 | 0 | 0 | 15.94 | 2.23 | 15.80 | 47.81 |
| Age≥30 (n = 1) | 6.54 | 0 | 6.54 | 0 | 0 | 0 | 11.69 | 0 | 11.69 | 0 | 0 | 0 | 18.23 | 0 | 18.23 | 18.23 |
| 8.07 | 3.11 | 9.16 | 7.55 | 3.24 | 9.38 | 5.29 | 3.11 | 6.05 | 5.93 | 5.16 | 10.37 | 26.83 | 8.59 | 26.21 | 2441.56 | |
| Age <30 (n = 64) | 7.69 | 3.02 | 8.71 | 7.84 | 3.20 | 9.38 | 4.58 | 2.59 | 4.83 | 6.65 | 5.02 | 10.37 | 26.75 | 8.76 | 26.21 | 1711.99 |
| Age≥30 (n = 27) | 8.97 | 3.21 | 10.14 | 6.86 | 3.28 | 9.38 | 6.97 | 3.59 | 6.05 | 4.23 | 5.19 | 0 | 27.02 | 8.34 | 26.21 | 729.57 |
1USD = 1199.07 MMK in 2015 average exchange rate, PID = Pelvic Inflammatory Disease; PIH = Pregnancy Induced Hypertension; APH = Ante-partum hemorrhage; PPH = Post-partum hemorrhage.
Description of potential predictor variables (n = 91).
| Variables |
|---|
| Age: mean = 26.75 year |
Fitted direct medical cost model (n = 87).
| Unstandardized Coefficients | T | Sig. | 95.0% Confidence Interval for B | |||
|---|---|---|---|---|---|---|
| B | Std. Error | Lower Bound | Upper Bound | |||
| (Constant) | 9.602 | .048 | 198.724 | .000 | 9.506 | 9.698 |
| Incomplete abortion (IA) | .901 | .025 | 35.808 | .000 | .851 | .951 |
| Prolonged labor (PL) | .947 | .032 | 29.587 | .000 | .883 | 1.011 |
| Post-partum hemorrhage (PPH) | .649 | .028 | 23.450 | .000 | .594 | .704 |
| Pregnancy induced hypertension (PHI) | .407 | .027 | 15.008 | .000 | .353 | .460 |
| Patient age | .006 | .002 | 3.495 | .001 | .003 | .009 |
| Septicemia | .133 | .042 | 3.206 | .002 | .051 | .216 |
Predicted cost of significant obstetric complication from fitted model.
| Significant obstetric complication | Predicted cost (USD) |
|---|---|
| Incomplete abortion | 35.75 |
| Prolonged labor | 37.43 |
| Post-partum hemorrhage | 27.79 |
| Pregnancy induced hypertension | 21.82 |
| Septicemia | 16.59 |
1USD = 1199.07 MMK in 2015 average exchange rate